Open Access Journals In Lipid Metabolism
Lipid metabolism starts in the intestine, where pancreatic lipases break down the ingested triglycerides into smaller chain fatty acids and eventually into monoglyceride molecules, enzymes that break down fats after bile salts emulsify them. When food reaches the small intestine in the form of chyme, the intestinal mucosa releases a digestive hormone, called cholecystokinin (CCK). CCK induces pancreatic lipase release from the pancreas and induces gallbladder contraction to expel accumulated bile salts into the intestine. CCK travels to the
brain too, where it can act as a suppressant of hunger. The pancreatic lipases and bile salts together break down triglycerides into free fatty acids. These fatty acids can be transferred across the gut membrane. When they cross the membrane, however, they are recombined to form triglyceride
molecules once again. Such triglycerides are packed within the intestinal
cells in phospholipid vesicles called chylomicrons along with cholesterol molecules.
High Impact List of Articles
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Ian C Lawrance
Review Article: Clinical Investigation
-
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Ian C Lawrance
Review Article: Clinical Investigation
Relevant Topics in Clinical